Rapid Micro Biosystems, Inc
rapidmicrobio.comRapid Micro Biosystems, Inc. (NASDAQ: RPID) is a life sciences technology company that sells automated microbial quality control systems to pharmaceutical manufacturers. Revenue comes from four streams: Growth Direct system sales, proprietary consumables, LIMS connection and other software, and services. The company pursues a land-and-expand model, placing initial systems at customer sites and then selling additional units across multiple suites and global facilities. As of December 31, 2025, 75% of the top 20 global pharmaceutical companies by revenue were customers. Gross margin improved from (24.4)% in FY2023 to (0.4)% in FY2024 to 3.1% in FY2025, with the company still operating at a net loss. Net cash used in operating activities was $31.1 million in FY2025 versus $44.2 million in FY2024. Primary manufacturing is in Lowell, Massachusetts, with a backup consumables facility in Lexington, Massachusetts, and third-party logistics in Oss, Netherlands. The company holds 12 granted U.S. patents and 72 issued foreign patents covering the Growth Direct platform, with expirations between 2032 and 2045.
Products & Services
Growth Direct automated microbial quality control platform, proprietary consumables (growth media and cassettes), LIMS connection software, and after-sales services including validation support.
Revenue Model
Capital equipment sales (Growth Direct systems), recurring proprietary consumables, LIMS and software licenses, and post-sale services. System revenue is transactional and concentrated among a small group of customers each period; consumables provide recurring pull-through revenue on a per-system basis.
Customers & Markets
Pharmaceutical manufacturers requiring microbial quality control testing in production environments. 75% of the top 20 global pharmaceutical companies by revenue were customers as of the FY2025 10-K filing. The majority of customers operate multiple Growth Direct systems, and over 40% have deployed systems across multiple facility locations.
Geographic Exposure
Primary operations in Lowell and Lexington, Massachusetts. Sales through direct and indirect channels in North America, Europe, and Asia-Pacific. Third-party logistics warehouse in Oss, Netherlands. Foreign patent coverage includes Australia, Canada, China, Europe, India, Japan, and Mexico. Subject to EU GDPR and UK GDPR through a German subsidiary.
Financial Snapshot
Loading...
